Literature DB >> 7533662

Immunohistochemical quantitation of polycyclic aromatic hydrocarbon-DNA adducts in human lymphocytes.

G Motykiewicz1, E Małusecka, E Grzybowska, M Chorazy, Y J Zhang, F P Perera, R M Santella.   

Abstract

The formation of polycyclic aromatic hydrocarbon-DNA adducts was studied in peripheral blood lymphocytes obtained from men with occupational and environmental exposure. Subjects included coke factory workers, residents from the vicinity of the cokery, and rural region inhabitants (16 individuals in each exposure group). Adducts were determined by immunohistochemical analysis using a polyclonal antiserum recognizing benzo(a)pyrene and related polycyclic aromatic hydrocarbon diol epoxide-DNA adducts, a biotinylated secondary antiserum, and streptavidin-conjugated FITC. Propidium iodide was used to quantitate nuclear DNA. Dual fluorescence intensities were simultaneously measured with a Zeiss Axiovert microscope and a Bio-Rad MRC-600 argon laser scanning confocal attachment. Adducts were significantly elevated (P < 0.001) in both occupational and environmental groups, as compared to the rural control group by Mann-Whitney U test. The distribution of the data indicated the existence of cells with relatively higher adduct levels. The percentages of these so called "higher adduct-level cells" were 13.6, 11.5, and 3.7 in cokery workers, environmentally exposed individuals, and rural controls, respectively. The immunohistochemical method allows visualization and relative quantitation of polycyclic aromatic hydrocarbon-DNA adducts in individual lymphocytes. It requires a much smaller amount of blood than the previously used 32P-postlabeling and ELISA methods, which used isolated bulk DNA. It can also be used for adduct quantitation in biopsy material. The results of this pilot study indicate that this technique is a promising addition to biomonitoring studies.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7533662

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  7 in total

Review 1.  Polycyclic aromatic hydrocarbon-DNA adduct formation in prostate carcinogenesis.

Authors:  Benjamin A Rybicki; Nora L Nock; Adnan T Savera; Deliang Tang; Andrew Rundle
Journal:  Cancer Lett       Date:  2005-09-09       Impact factor: 8.679

2.  Human Biomonitoring of DNA Adducts by Ion Trap Multistage Mass Spectrometry.

Authors:  Jingshu Guo; Robert J Turesky
Journal:  Curr Protoc Nucleic Acid Chem       Date:  2016-09-01

Review 3.  Biomarkers of exposure to polycyclic aromatic hydrocarbons from environmental air pollution.

Authors:  G Castaño-Vinyals; A D'Errico; N Malats; M Kogevinas
Journal:  Occup Environ Med       Date:  2004-04       Impact factor: 4.402

4.  Associations between smoking, polymorphisms in polycyclic aromatic hydrocarbon (PAH) metabolism and conjugation genes and PAH-DNA adducts in prostate tumors differ by race.

Authors:  Nora L Nock; Deliang Tang; Andrew Rundle; Christine Neslund-Dudas; Adnan T Savera; Cathryn H Bock; Kristin G Monaghan; Allison Koprowski; Nicoleta Mitrache; James J Yang; Benjamin A Rybicki
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-06       Impact factor: 4.254

5.  Molecular epidemiological study of non-small-cell lung cancer from an environmentally polluted region of Poland.

Authors:  M Rusin; D Butkiewicz; E Malusecka; A Zborek; J Harasim; K Czyzewski; W P Bennett; P G Shields; A Weston; J A Welsh; S Krzyzowska-Gruca; M Chorazy; C C Harris
Journal:  Br J Cancer       Date:  1999-07       Impact factor: 7.640

6.  Bulky DNA adducts in human sperm associated with semen parameters and sperm DNA fragmentation in infertile men: a cross-sectional study.

Authors:  Guixiang Ji; Lifeng Yan; Shengmin Wu; Jining Liu; Lei Wang; Shenghu Zhang; Lili Shi; Aihua Gu
Journal:  Environ Health       Date:  2013-09-30       Impact factor: 5.984

Review 7.  Polycyclic aromatic hydrocarbons and PAH-related DNA adducts.

Authors:  Błaszczyk Ewa; Mielżyńska-Švach Danuta
Journal:  J Appl Genet       Date:  2016-12-12       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.